E-Textile Washability & Wear Patent Snapshot 2026
The e-textile washability and wear patent space comprises 9 patent families and is highly concentrated, with a single Canadian startup holding nearly half the corpus. Activity is in a growth phase on a multi-year basis, though annual volume has eased from its 2023 peak and the most recent periods remain understated by publication lag.
Texavie leads a nascent, tightly held field
TEXAVIE TECHNOLOGIES INC holds the top position with 4 patent families, followed by KINPO ELECTRONICS LTD with 2, while three academic institutions each hold 1 — making this one of the most concentrated emerging fields in wearable electronics.
The top five filers collectively account for 100% of the ranked applicants visible in this query’ combined total, confirming that no meaningful second tier has yet formed. The gap between the leader and all other applicants is substantial, leaving the field dominated by a single commercial actor.
| # | Applicant | Patent families | Share |
|---|---|---|---|
| 1 | TEXAVIE TECHNOLOGIES INC | 4 | |
| 2 | Kinpo Electronics Ltd | 2 | |
| 3 | Amity University Kolkata | 1 | |
| 4 | Guangdong University of Technology | 1 | |
| 5 | K R Mangalam University | 1 |
Texavie’s lead position, paired with a technical focus squarely on diagnostics, AI-driven health analytics, and healthcare informatics, signals that wash-durable e-textile innovation is being driven by medical wearable use cases rather than consumer fashion.
The most recent filing years are subject to standard patent publication lag of 18–24 months and likely understate current activity; the evidence snapshot should be re-evaluated as those publications clear. Longer-window growth, applicant concentration, and technology-route coverage are therefore more reliable signals than the latest-year bar alone.
A 2023 filing surge and a diagnostic-heavy technology mix
Two charts frame the field’s trajectory and technology composition: annual filing activity reveals an episodic growth pattern with a clear 2023 peak, while the IPC class breakdown shows a visible skew toward medical sensing and AI rather than textile chemistry.
Annual filing trend
Filings were effectively absent from 2017 through 2020, rose to a single filing in 2021, then surged to 4 in 2023 before receding. The 2024 and 2025 figures are almost certainly understated due to publication lag and should not be read as a real decline; the three-year recent window sits well above the prior equivalent period, confirming net growth.
↗ Hover for values · click a bar to ask EurekaTechnology composition
A61B (Diagnosis & surgery) and D06M (Textile chemical treatment) are visible in the IPC mix, with G06N (AI models) and G16H (Healthcare informatics) also prominent. H05K (Printed circuits & assemblies) and the textile-chemistry branches represent smaller shares, pointing to an opportunity space in durable interconnect and substrate engineering that remains comparatively sparse.
↗ Hover for values · click a bar to ask EurekaHighly cited patent families surfaced by the query
Citation-heavy patent families returned by the query. Use this section as citation context, not as a curated list of the most topic-specific patents.
Transfer printing paper and manufacturing method o…
A transfer printing paper is provided. The transfer printing paper includes a release layer and a conductive layer. The conductive layer is formed on the release layer and is suitable for being transferred to a flexible material layer. After being transferred to the flexible material layer, the conductive layer is configured to be electrically in contact… (excerpt from the patent abstract)
| # | Patent | Citations |
|---|---|---|
| 1 | Stretchable textile sensor wearable device for tra… | 3 |
| 2 | Transfer printing paper and manufacturing method o… | 3 |
Ranked by total forward citations. Citation counts favour older and broadly cited patent families, and broad or adjacent patents may appear when they match the search scope. Treat this section as citation context, not as a curated list of the most topic-specific patents. Some patent titles may be shown in their original, non-English language where an accurate translation could not be guaranteed.
Assignee snapshot from the current evidence set
The applicants below are visible in this query result. Because the evidence set is relatively small, read this section as a directional snapshot rather than a full competitive ranking.
TEXAVIE TECHNOLOGIES INC
Texavie holds 4 patent families, making it the corpus leader by a wide margin. Its technology emphasis spans A61B 5 (Diagnosis & surgery), G06N 20 (AI models), and G16H 50 (Healthcare informatics) — all at 4 filings each — indicating a tightly integrated health-monitoring thesis. Momentum is flagged as a new entrant, consistent with concentrated recent activity rather than a long filing history.
4 patent familiesKINPO ELECTRONICS LTD
Kinpo Electronics holds 2 patent families, focused on A61B 5 (Diagnosis & surgery) and H05K 1 and H05K 3 (Printed circuits & assemblies). This combination of sensing and PCB assembly expertise positions Kinpo as the primary hardware-oriented challenger, differentiating it from Texavie’s software and analytics emphasis. Momentum data for Kinpo is not separately reported in the evidence.
2 patent familiesFrequently asked questions
The current corpus stands at 9 patent families globally. This is a very small field by patent-landscape standards, reflecting either genuine novelty of the problem space, under-filing relative to the research activity, or both.
TEXAVIE TECHNOLOGIES INC leads with 4 patent families. Its portfolio is concentrated in medical diagnostics, AI-based health models, and healthcare informatics, suggesting a wearable health-monitoring thesis underpins its washability and durability work.
The field is in a Growth lifecycle stage. The recent three-year filing window is 300% above the prior equivalent period. Annual volume peaked in 2023 and has eased since, but the most recent years are understated by publication lag and should not be interpreted as a real decline.
India and the United States each have 2 patent records, followed by Canada, China, Europe (EPO), Singapore, and WIPO (PCT) each with 1. PCT coverage is limited, indicating that broad multi-jurisdiction blocking positions have not yet been established by any filer.
No co-applicant filings have been identified in this corpus. All five active applicants have filed independently, despite three of them being academic institutions where cross-sector collaboration might be expected.
H05K (Printed circuits & assemblies) is the largest white-space branch with only 2 patent records and a 6% IPC share, pointing to wash-durable flexible interconnects and conformal encapsulation as comparatively open areas. B41C and B41M (printing processes relevant to conductive-ink textile patterning) each appear only once and are similarly sparse.
Built on Patsnap Open Platform
This report’s underlying patent dataset — filings, assignees, technology clusters — is open for developers via MCP and REST API. Free to start, 10,000 credits, no credit card required.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.